Valuation
Login to View
Max Portfolio %
Login to View
TMBR RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2022 | 929.0K | 540.2K | 273.2K | 83.2K |
| 2021 | 467.6K | 856.5K | 798.9K | 886.5K |
| 2020 | 302.4K | 297.4K | 404.4K | 453.8K |
| 2019 | 57.0K | 0 | 256.6K | 285.5K |
| 2018 | 73.0K | 72.0K | 79.0K | 71.0K |
| 2017 | 100.0K | 86.0K | 84.0K | 69.0K |
| 2016 | 64.0K | 93.0K | 107.0K | 120.0K |
| 2015 | 53.7K | 56.3K | 58.8K | 61.4K |
| 2013 | 25.5K | 25.6K | 51.1K | 0 |
| 2012 | 41.5K | 34.6K | 27.8K | 28.5K |
| 2011 | 0 | 0 | 55.2K | 48.3K |
| 2010 | 0 | 0 | 0 | 0 |
| Â CEO | Mr. John Koconis M.B.A. |
|---|---|
| Â WEBSITE | timberpharma.com |
| Â SECTOR | Healthcare |
| Â INDUSTRY | Biotechnology |
| Â EMPLOYEES | 9 |